JP2009500314A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009500314A5 JP2009500314A5 JP2008518963A JP2008518963A JP2009500314A5 JP 2009500314 A5 JP2009500314 A5 JP 2009500314A5 JP 2008518963 A JP2008518963 A JP 2008518963A JP 2008518963 A JP2008518963 A JP 2008518963A JP 2009500314 A5 JP2009500314 A5 JP 2009500314A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- agents
- peptide
- agent according
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69513605P | 2005-06-29 | 2005-06-29 | |
| PCT/GB2006/002390 WO2007000601A2 (en) | 2005-06-29 | 2006-06-28 | Gene regulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009500314A JP2009500314A (ja) | 2009-01-08 |
| JP2009500314A5 true JP2009500314A5 (https=) | 2009-08-20 |
Family
ID=37595498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008518963A Pending JP2009500314A (ja) | 2005-06-29 | 2006-06-28 | 遺伝子調節 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20090286738A1 (https=) |
| EP (1) | EP1909811B1 (https=) |
| JP (1) | JP2009500314A (https=) |
| AT (1) | ATE543504T1 (https=) |
| WO (1) | WO2007000601A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012513218A (ja) * | 2008-12-23 | 2012-06-14 | ヴィヴォスクリプト，インコーポレイテッド | 遺伝子改変を伴わずに細胞を再プログラミングするための組成物および方法 |
| GB2543550A (en) * | 2015-10-21 | 2017-04-26 | Hox Therapeutics Ltd | Peptides |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997042222A1 (en) * | 1996-05-08 | 1997-11-13 | Cyclacel Limited | Methods and means for inhibition of cdk4 activity |
| US20020086383A1 (en) * | 2000-02-23 | 2002-07-04 | Guy Sauvageau | Hematopoietic stem cell expansion enhancing factor and method of use |
| GB0229151D0 (en) * | 2002-12-13 | 2003-01-15 | St Georges Entpr Ltd | Product and method |
-
2006
- 2006-06-28 WO PCT/GB2006/002390 patent/WO2007000601A2/en not_active Ceased
- 2006-06-28 EP EP06755670A patent/EP1909811B1/en not_active Not-in-force
- 2006-06-28 AT AT06755670T patent/ATE543504T1/de active
- 2006-06-28 US US11/993,978 patent/US20090286738A1/en not_active Abandoned
- 2006-06-28 JP JP2008518963A patent/JP2009500314A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010536714A5 (https=) | ||
| JP7175506B2 (ja) | 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ | |
| JP2009500431A5 (https=) | ||
| JP2013155195A5 (https=) | ||
| JP2012115277A5 (https=) | ||
| JP2010512795A5 (https=) | ||
| JP2004536077A5 (https=) | ||
| WO2011149964A3 (en) | Methods for treating or preventing vascular graft failure | |
| JP2012530060A5 (https=) | ||
| JP2004521123A5 (https=) | ||
| JP2011518176A5 (https=) | ||
| JP7606966B2 (ja) | ミトコンドリア病を標的とするアナログ | |
| JP7667091B2 (ja) | Ｍａｓｐ阻害化合物およびその使用 | |
| SK145993A3 (en) | Antiretroviral hydrazine derivatives | |
| CN113544138A (zh) | 线粒体靶向肽 | |
| Peng et al. | Synthesis and activity of tumor-homing peptide iRGD and histone deacetylase inhibitor valproic acid conjugate | |
| JP2009500314A5 (https=) | ||
| JP2015514771A5 (https=) | ||
| ES2744474T3 (es) | Fragmentos polipeptídicos de168A-T2 y composiciones que los comprenden para uso en el tratamiento del cáncer | |
| JP2018533570A5 (https=) | ||
| JP2008508363A5 (https=) | ||
| CA2634902A1 (en) | Anticancer agent comprising a peptide | |
| US20210269482A1 (en) | Peptoid-peptide macrocycles, pharmaceutical compositions and methods of using the same | |
| WO2009067225A3 (en) | Boceprevir derivatives for the treatment of hcv infections | |
| JPWO2022244876A5 (https=) |